ES2036729T3 - Antibiotico antitumoral bu-3862t. - Google Patents

Antibiotico antitumoral bu-3862t.

Info

Publication number
ES2036729T3
ES2036729T3 ES198989103764T ES89103764T ES2036729T3 ES 2036729 T3 ES2036729 T3 ES 2036729T3 ES 198989103764 T ES198989103764 T ES 198989103764T ES 89103764 T ES89103764 T ES 89103764T ES 2036729 T3 ES2036729 T3 ES 2036729T3
Authority
ES
Spain
Prior art keywords
antitumoral
antibiotic
diacetile
tunors
atcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989103764T
Other languages
English (en)
Inventor
Koko Sugawara
Masami Hatori
Hideo Kamei
Masataka Konishi
Toshikazu Oki
Koji Tomita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2036729T3 publication Critical patent/ES2036729T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/55—Streptomyces hygroscopicus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN ANTIBIOTICO ANTITUMORAL NUEVO, DESIGNADO AQUI COMO BU - 3862T SE PRODUCE POR FERMENTACION DE STREPTOMYCES HYGROSCOPIUS ATCC 53709. EL BU - 3862T Y SUS DERIVADOS DIACETILO Y DIHIDRO INHIBEN EL CRECIMIENTO DE TUNORES EN ANIMALES DE EXPERIMENTACION.
ES198989103764T 1988-03-07 1989-03-03 Antibiotico antitumoral bu-3862t. Expired - Lifetime ES2036729T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/165,337 US4912133A (en) 1988-03-07 1988-03-07 BU-3862T antitumor antibiotic

Publications (1)

Publication Number Publication Date
ES2036729T3 true ES2036729T3 (es) 1993-06-01

Family

ID=22598495

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989103764T Expired - Lifetime ES2036729T3 (es) 1988-03-07 1989-03-03 Antibiotico antitumoral bu-3862t.

Country Status (17)

Country Link
US (1) US4912133A (es)
EP (1) EP0332080B1 (es)
JP (1) JP2821756B2 (es)
KR (1) KR960016206B1 (es)
AT (1) ATE76406T1 (es)
AU (1) AU618790B2 (es)
CA (1) CA1338184C (es)
DE (1) DE68901552D1 (es)
DK (1) DK173937B1 (es)
ES (1) ES2036729T3 (es)
FI (1) FI90991C (es)
GR (1) GR3004756T3 (es)
IE (1) IE62211B1 (es)
IL (1) IL89477A (es)
NO (1) NO174432C (es)
PT (1) PT89917B (es)
ZA (1) ZA891695B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071957A (en) * 1989-08-04 1991-12-10 Bristol-Myers Company Antibiotic BU-4061T
EP1463719A2 (en) 2002-01-08 2004-10-06 Eisai Co., Ltd Eponemycin and epoxomicin analogs and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474800A (en) * 1980-05-13 1984-10-02 Taisho Pharmaceutical Co., Ltd. Epoxysuccinyl amino acid derivatives
JPS5865287A (ja) * 1981-10-14 1983-04-18 Nippon Chemiphar Co Ltd ベーターアミノアルコール誘導体と，心筋梗塞の予防および治療剤
JPS58116412A (ja) * 1981-12-29 1983-07-11 Taisho Pharmaceut Co Ltd 直腸投与製剤
JPS608223A (ja) * 1983-06-28 1985-01-17 Taisho Pharmaceut Co Ltd 抗アレルギ−剤

Also Published As

Publication number Publication date
NO890944L (no) 1989-09-08
CA1338184C (en) 1996-03-26
FI891001L (fi) 1989-09-08
DE68901552D1 (de) 1992-06-25
EP0332080A1 (en) 1989-09-13
JPH0272167A (ja) 1990-03-12
NO174432C (no) 1998-06-09
EP0332080B1 (en) 1992-05-20
NO890944D0 (no) 1989-03-06
FI90991C (fi) 1994-04-25
IE890724L (en) 1989-09-07
IL89477A (en) 1994-11-28
AU3104189A (en) 1989-09-07
DK173937B1 (da) 2002-02-25
FI891001A0 (fi) 1989-03-02
JP2821756B2 (ja) 1998-11-05
AU618790B2 (en) 1992-01-09
ZA891695B (en) 1989-11-29
ATE76406T1 (de) 1992-06-15
PT89917B (pt) 1994-05-31
DK107189A (da) 1989-09-08
IE62211B1 (en) 1995-01-11
KR890014102A (ko) 1989-10-21
KR960016206B1 (ko) 1996-12-06
FI90991B (fi) 1994-01-14
IL89477A0 (en) 1989-09-10
NO174432B (no) 1994-01-24
GR3004756T3 (es) 1993-04-28
DK107189D0 (da) 1989-03-06
US4912133A (en) 1990-03-27
PT89917A (pt) 1989-11-10

Similar Documents

Publication Publication Date Title
DK165461C (da) Biologisk ren kultur af mikroorganismen streptomyces cyaneogriseus noncyanogenes ll-f28249 med deponeringsnummeret nrrl 15773
DE69012384D1 (de) BMY-41950-Antitumor-Antibiotikum.
SE8502135D0 (sv) 4'-deschlororebeccamycin and process for its preparation
ATE37394T1 (de) Antitumor-antibiotika.
SE8502996L (sv) Antibiotisk antitumorforening
ES2002011A6 (es) Un procedimiento para preparar un complejo de antibiotico aad-609
AU2971189A (en) Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
DK107189D0 (da) Antitumor aktive forbindelser
ATE82577T1 (de) Antitumor-antibiotika.
FI872860A0 (fi) Antibiotikum a 42867 och dess additionssalter.
AU562464B2 (en) Macrolide ptl-448-a,b,c and d
EP0376609A3 (en) Antibiotic a80915 and process for its production
ES2060962T3 (es) Antibioticos glicopeptidicos.
DE69124390D1 (de) Polycyclisches etherantibiotikum mit anticoccidose- und wachstumsförderungsaktivität
FR2201074A1 (en) Antibiotic violamycin - with antitumour, virucidal and antimycoplasma activity

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332080

Country of ref document: ES